According to Statifacts, the global clinical trials market size is calculated at USD 126.30 billion in 2025 and is expected to reach around USD 186.09 billion by 2034, growing at a CAGR of 4.4% from ...

bAnaesthesia and Intensive Care, Department of Clinical Sciences Lund and Lund University Agenda 2030 Graduate School, Lund University, Lund, Sweden cDepartment of Health Research Methods, Evidence, ...

Blinding of the study will be maintained to preserve trial integrity. The company has informed BEACON-IPF clinical trial investigators and is in the process of informing global regulatory authorities.

Cancer Prevention Research publishes articles that focus on cancer prevention, preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis ...

A clinical trial is one that involves human participants and seeks to answer specific questions about a type of medical intervention. This can be a drug or other type of treatment, such as nutritional ...

Correspondence to Dr Thomas Bandholm, Dept of Clinical Research, Copenhagen University Hospital, Amager and Hvidovre, Hvidovre DK-2650, Denmark; thomas.quaade.bandholm{at}regionh.dk The REPORT guide ...

Objectives Clinical trials (CTs) are considered an important method for developing new treatments and providing access to potentially effective drugs that are still under investigation. Measuring the ...

Methods and analysis We will identify randomised control trials comparing treatment with β-blockers, versus placebo or standard care in adults with sepsis. Data sources will include MEDLINE, EMBASE, ...

ICON Public Limited Company (NASDAQ:ICLR) provides outsourced clinical research and commercialization services, supporting all stages of clinical development for pharmaceutical, biotechnology ...

In this article, we are going to take a look at where ICON Public Limited Company (NASDAQ ... The reason is simple: our research has shown that we can outperform the market by imitating the ...

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial intelligence (AI ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial ...